Tokyo Tape
Sign in
← DVx

Quarterly report · Q2

3079.TEDINET S100PILK
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
MetricValuePeriodScopeSource row
Revenue¥23.6bn2022-04-01 → 2022-09-30StandaloneNet sales
Revenue¥45.5bn2021-04-01 → 2022-03-31StandaloneNet sales (5-year summary)
Revenue¥22.0bn2021-04-01 → 2021-09-30StandaloneNet sales
Operating income¥598m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income¥523m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income¥615m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income¥1.3bn2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥524m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax¥613m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax¥524m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income¥417m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income¥863m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income¥360m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥23.4bnat 2022-09-30StandaloneAssets
Total assets¥22.2bnat 2022-03-31StandaloneAssets
Total assets¥21.4bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥14.6bnat 2022-09-30StandaloneLiabilities
Total liabilities¥13.6bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥8.8bnat 2022-09-30StandaloneNet assets
Net assets / equity¥8.6bnat 2022-03-31StandaloneNet assets
Net assets / equity¥8.1bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥8.8bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥7.8bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥8.8bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥7.8bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥7.1bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥6.5bnat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥1.7bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥895m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥28m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥97m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥26m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥255m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥235m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥248m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥40.192022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.72022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.562021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥34.892021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥19.62021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥40.122022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥83.332021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥34.82021-04-01 → 2021-09-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥252021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Equity ratio37.5%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.6%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio37.7%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued10,780,000at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued10,780,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued10,780,000at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥1.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥1.7bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥20.3bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥20.3bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥1.6bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.6bn
—segment totalrevenue2022-04-01 → 2022-09-30¥21.9bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥21.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥1.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥1.4bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥19.1bn
jpcrp040300-q2r_E03005-000Arrhythmia Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥19.1bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E03005-000Ischemia Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.5bn
—segment totalrevenue2021-04-01 → 2021-09-30¥20.6bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥20.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 459
ItemContextValueUnit
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1419032000JPY
Revenues from external customersPrior1YTDDuration_NonConsolidatedMember22032433000JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsPrior1YTDDuration_NonConsolidatedMember－JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember19114489000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember1498911000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember20613400000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1419032000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember22032433000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember2052519000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember309582000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember2362101000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember157709000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember2519810000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember20292327000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember1632197000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember21924524000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1693719000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember23618244000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember20292327000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember1632197000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember21924524000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1693719000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember23618244000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000ArrhythmiaBusinessReportableSegmentMember2241385000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E03005-000IschemiaBusinessReportableSegmentMember188648000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember2430034000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember200721000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember2630755000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第37期第２四半期(自　2022年７月１日　至　2022年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)ディーブイエックス株式会社
Company name in english cover pageFilingDateInstantDVx Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　柴﨑　浩
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都豊島区高田二丁目17番22号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-5985-6123（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　　宮本　聡
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都豊島区高田二丁目17番22号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-5985-6123（代表）

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass